Assignee
SHANGHAI SHENGDI PHARMACEUTICAL CO LTD
CN·1 granted patent·2 pending applications·0 citations·filing 2020–2023
Top patents by PatentIndex Score
3 records- 0152US2025152722A1Drug conjugate of glucocorticoidSHANGHAI SHENGDI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0249US2024016822A1Use of nk1 antagonist prodrug compound in combination with 5-ht3 receptor antagonistSHANGHAI SHENGDI PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 0341US12421260B2Neurokinin-1 antagonistSHANGHAI SHENGDI PHARMACEUTICAL CO LTD·Filed 2020·Granted Sep 23, 2025·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when SHANGHAI SHENGDI PHARMACEUTICAL CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →